In conclusion,this meta-analysis showed that the mTOR polymorphisms (rs2295080 and rs11121704) were associated with cancer risk and clinical outcomes of cancer patients, respectively, and no any association was found for the rs2536 polymorphism. The gene discussed is MTOR; the disease is cancer.